John Gibbs, a former Trump administration official, has received over $425,000 from the Democratic Party.
By Chris Hedges, The Real News
The Democratic Party is engaged in a dangerous and failed electoral strategy. Rather than appealing to the majority working-class, non-Republican electorate, the party is courting right-wing politicians like Liz Cheney while funding far-right Republican candidates in this year’s primary elections. This approach resembles the disastrous Hillary Clinton campaign’s “Pied Piper” ploy of promoting the supposedly “more beatable” Trump in the 2016 Republican presidential primaries. Why is the Democratic Party lavishly funding Trump stooges such as John Gibbs, a former Trump administration official who claimed that Joe Biden’s 2020 election victory was “mathematically impossible?” Why do they see the stoking of fascist fire as an effective campaign strategy? Even The New York Times has called the tactic of funding far-right pro-Trump candidates a “Cynical Low for the Democratic Party.” Historian Paul Street joins The Chris Hedges Report to discuss what is taking place on our bizarre political landscape as we head towards the midterm elections.
Recent Posts
Washington, DC, Residents Protest Against Trump
September 7, 2025
Take Action Now Several thousand protesters march to oppose Trump’s troop deployment Justice Department data shows violent crime at 30-year low…
‘Shameful Assault on Human Rights’: Trump Sanctions Palestinian Orgs That Called for UN to Investigate Israeli War Crimes
September 6, 2025
Take Action Now The former executive director of Human Rights Watch said Trump’s “answer to Israeli atrocities is to censor reporting on…
Hegseth Doesn’t Rule Out Regime Change In Venezuela, Suggests More U.S. Strikes On Boats Are Coming
September 5, 2025
Take Action Now When asked if the goal was regime change in Venezuela, Hegseth said that was a “presidential decision” and added that “we’re prepared…
Secretary Kennedy Doesn’t Care About Long COVID Patients
September 5, 2025
Take Action Now Reckless funding cuts have dealt a significant blow to ongoing research, derailing NIH-funded clinical trials on antivirals and…